These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28993411)

  • 1.
    Tschida BR; Temiz NA; Kuka TP; Lee LA; Riordan JD; Tierrablanca CA; Hullsiek R; Wagner S; Hudson WA; Linden MA; Amin K; Beckmann PJ; Heuer RA; Sarver AL; Yang JD; Roberts LR; Nadeau JH; Dupuy AJ; Keng VW; Largaespada DA
    Cancer Res; 2017 Dec; 77(23):6576-6588. PubMed ID: 28993411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression.
    Lo LH; Lam CY; To JC; Chiu CH; Keng VW
    Biochem Biophys Res Commun; 2021 Feb; 541():70-77. PubMed ID: 33482578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
    Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
    J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.
    Kodama T; Newberg JY; Kodama M; Rangel R; Yoshihara K; Tien JC; Parsons PH; Wu H; Finegold MJ; Copeland NG; Jenkins NA
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3384-93. PubMed ID: 27247392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
    Keng VW; Villanueva A; Chiang DY; Dupuy AJ; Ryan BJ; Matise I; Silverstein KA; Sarver A; Starr TK; Akagi K; Tessarollo L; Collier LS; Powers S; Lowe SW; Jenkins NA; Copeland NG; Llovet JM; Largaespada DA
    Nat Biotechnol; 2009 Mar; 27(3):264-74. PubMed ID: 19234449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.
    Keng VW; Sia D; Sarver AL; Tschida BR; Fan D; Alsinet C; Solé M; Lee WL; Kuka TP; Moriarity BS; Villanueva A; Dupuy AJ; Riordan JD; Bell JB; Silverstein KA; Llovet JM; Largaespada DA
    Hepatology; 2013 Jan; 57(1):120-30. PubMed ID: 22899566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.
    Stauffer JK; Scarzello AJ; Andersen JB; De Kluyver RL; Back TC; Weiss JM; Thorgeirsson SS; Wiltrout RH
    Cancer Res; 2011 Apr; 71(7):2718-27. PubMed ID: 21324921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
    Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
    Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model.
    Bard-Chapeau EA; Nguyen AT; Rust AG; Sayadi A; Lee P; Chua BQ; New LS; de Jong J; Ward JM; Chin CK; Chew V; Toh HC; Abastado JP; Benoukraf T; Soong R; Bard FA; Dupuy AJ; Johnson RL; Radda GK; Chan EC; Wessels LF; Adams DJ; Jenkins NA; Copeland NG
    Nat Genet; 2014 Jan; 46(1):24-32. PubMed ID: 24316982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma.
    Kodama T; Bard-Chapeau EA; Newberg JY; Kodama M; Rangel R; Yoshihara K; Ward JM; Jenkins NA; Copeland NG
    Gastroenterology; 2016 Aug; 151(2):324-337.e12. PubMed ID: 27178121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
    Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice.
    Riordan JD; Feddersen CR; Tschida BR; Beckmann PJ; Keng VW; Linden MA; Amin K; Stipp CS; Largaespada DA; Dupuy AJ
    Hepatology; 2018 Mar; 67(3):924-939. PubMed ID: 28961327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
    Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection.
    Yu S; Vernia S
    Methods Mol Biol; 2020; 2164():129-143. PubMed ID: 32607890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
    Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
    PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system.
    Dupuy AJ; Akagi K; Largaespada DA; Copeland NG; Jenkins NA
    Nature; 2005 Jul; 436(7048):221-6. PubMed ID: 16015321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.
    Orci LA; Lacotte S; Oldani G; Slits F; De Vito C; Crowe LA; Rubbia-Brandt L; Vallée JP; Morel P; Toso C
    Br J Surg; 2016 Mar; 103(4):417-26. PubMed ID: 26891212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.